Brian P. Bourke

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

Abdominal obesity and metabolic syndrome

The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease

The metabolic syndrome

Trial of Tocilizumab in Giant-Cell Arteritis

Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial

The metabolic syndrome

Clinical features of polymyalgia rheumatica and giant cell arteritis

Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis

Lipodystrophies: rare disorders causing metabolic syndrome

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK

Insulin and insulin resistance:

Diagnosis and Management of the Metabolic Syndrome

The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy

Facial nerve injury during temporal artery biopsy

Incidence of Giant Cell Arteritis and Characteristics of Patients: Data‐Driven Analysis of Comorbidities

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis

Design of the Tocilizumab in Giant Cell Arteritis Trial

Cardiovascular toxicities associated with immune checkpoint inhibitors

BSR and BHPR guidelines for the management of polymyalgia rheumatica

BSR and BHPR guidelines for the management of giant cell arteritis

Progression from partial to generalised lipodystrophy — a case report

Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica